Role of CD91 and its ligands in immune response
Role of CD91 and its ligands in immune response
批准号:
8488395
负责人:
Robert J Binder
金额:
$30.88万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2015-06-30
关键词:
Antigen-Presenting CellsAntigensBloodCell Surface ReceptorsCellsCommunicable DiseasesComplexCross-PrimingDown-RegulationEventFamilyHeat shock proteinsImmune responseImmune systemImmunizationKnockout MiceLigandsMacroglobulinsMalignant NeoplasmsMediatingMolecular ChaperonesMusPathway interactionsPeptidesProcessPropertyProphylactic treatmentProteinsRoleSerumSystemT cell responseTestingTherapeutic AgentsTumor-Derivedalpha 2-Glucoproteinscalreticulincancer immunotherapycancer therapyimmunogenicityinhibitor/antagonistnovel therapeuticsreceptorresponsetraffickingtumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Heat shock proteins (HSPs) of the hsp70, hsp90 and calreticulin families are abundant soluble
intracellular proteins that elicit powerful immunological responses. These responses include
components of both the innate and adaptive aspects of T cell responses as well as its down regulation.
The ability of HSPs to chaperone peptides and engage internalizing receptors on antigen presenting
cells are two key properties that allow them to elicit immune responses. A key role for HSPs in cross-
priming of antigens during T cell responses was also envisaged and demonstrated in 2005.
In this application we aim to (i) investigate the role of the HSP receptor, CD91, in cross-priming in the
murine system, (ii) examine the mechanism of immunogenicity of alpha2-macroglobulin (¿2M), a CD91
ligand, complexed either endogenously and artificially to various peptides, and (iii) test the role of
serum levels of ¿2M on the ability of mice to mount immune responses.
Aim 1: To investigate the role of the HSP receptor CD91 in cross-priming of T cell responses.
a. Determine the ability of RAP (a competitive inhibitor of CD91) -expressing cells to cross present
antigens and mount effective T cell responses;
b. Creation of a CD91 conditional knock-out mouse and the characterization of immunological
responses in this mouse.
Aim 2: To investigate the mechanism of ¿2M-mediated immunogenicity and its application to
immunotherapy of cancer and infectious disease.
a. Examine the mechanism of co-stimulatory activation by ¿2M;
b. Examination of the intracellular trafficking and processing of ¿2M-peptide complexes.
c. Test the complexes of tumor derived-peptides with ¿2M in prophylaxis and therapy of cancers;
d. Examination of endogenously formed ¿2M-peptide complexes as immunogens.
Aim 3: To investigate the role of blodd ¿2M levels on immune system.
a. Test the effects of blood ¿2M levels on the ability of mice to elicit T cell responses after tumor
inoculation;
b. Test the effects of blood ¿2M levels on the ability of mice to elicit T cell responses after
immunization with HSP-peptide complexes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CD91 and cancer immunosurveillance
-
批准号:10308038
-
项目类别:
-
资助金额:$34.78万
-
财政年份:2019
-
负责人:Robert J Binder
-
依托单位:
CD91 and cancer immunosurveillance
-
批准号:9897031
-
项目类别:
-
资助金额:$35.49万
-
财政年份:2019
-
负责人:Robert J Binder
-
依托单位:
CD91 and cancer immunosurveillance
-
批准号:10524051
-
项目类别:
-
资助金额:$34.78万
-
财政年份:2019
-
负责人:Robert J Binder
-
依托单位:
Heat shock protein gp96 and Treg responses
-
批准号:9606843
-
项目类别:
-
资助金额:$19.43万
-
财政年份:2018
-
负责人:Robert J Binder
-
依托单位:
Heat shock proteins and modulation of immune responses
-
批准号:9307761
-
项目类别:
-
资助金额:$16.81万
-
财政年份:2016
-
负责人:Robert J Binder
-
依托单位:
Role of CD91 and its ligands in immune response
-
批准号:8094481
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2009
-
负责人:Robert J Binder
-
依托单位:
Role for alpha2-Macroglobulin in Immune Responses and Cancer Immunotherapy
-
批准号:7573852
-
项目类别:
-
资助金额:$15.19万
-
财政年份:2009
-
负责人:Robert J Binder
-
依托单位:
Role of CD91 and its ligands in immune response
-
批准号:8290437
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2009
-
负责人:Robert J Binder
-
依托单位:
Role of CD91 and its ligands in immune response
-
批准号:7727754
-
项目类别:
-
资助金额:$33.15万
-
财政年份:2009
-
负责人:Robert J Binder
-
依托单位:
Role of CD91 and its ligands in immune response
-
批准号:7877729
-
项目类别:
-
资助金额:$33.18万
-
财政年份:2009
-
负责人:Robert J Binder
-
依托单位:
Role for alpha2-Macroglobulin in Immune Responses and Cancer Immunotherapy
-
批准号:8103864
-
项目类别:
-
资助金额:$16.0万
-
财政年份:2009
-
负责人:Robert J Binder
-
依托单位:
Role for alpha2-Macroglobulin in Immune Responses and Cancer Immunotherapy
-
批准号:7886878
-
项目类别:
-
资助金额:$15.59万
-
财政年份:2009
-
负责人:Robert J Binder
-
依托单位:
Cancer Immunology Training Program
-
批准号:10492141
-
项目类别:
-
资助金额:$34.73万
-
财政年份:1999
-
负责人:Robert J Binder
-
依托单位:
Cancer Immunology Training Program
-
批准号:10670409
-
项目类别:
-
资助金额:$51.87万
-
财政年份:1999
-
负责人:Robert J Binder
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: